Bone Biologics (BBLG) Change in Acquisitions & Divestments (2014)

Bone Biologics (BBLG) reported Change in Acquisitions & Divestments of $18557.0 for Q2 2014, down 1.4% quarter-over-quarter from $18820.0 in Q1 2014.

Bone Biologics (BBLG) Change in Acquisitions & Divestments (2014) Analysis & Trends

Bone Biologics (BBLG) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $18557.0 in Q2 2014.

Change in Acquisitions & Divestments for Q2 2014 came in at $18557.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was $37377.0 (changed N/A YoY), and the FY2014 annual result was $37377.0, changed N/A from the prior year.
Change in Acquisitions & Divestments fell to $18557.0 in Q2 2014 per BBLG's latest filing, from $18820.0 in the prior quarter.
Over five years, Change in Acquisitions & Divestments peaked at $18820.0 in Q1 2014 and troughed at $18557.0 in Q2 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn
9	Abivax	95.45 Bn	95.45 Bn	-
10	Bone Biologics	1.47 Mn	1.47 Mn	-

Download Data